Home Health M&A Activity Expected to Climb Following PDGM, Bankruptcies

Cash flow interruptions and operational changes caused by the Patient-Driven Groupings Model (PDGM) may lead to a spike in the number of home health providers in the U.S. filing for bankruptcy, some experts predict. If the forecast is accurate, that may also mean more initial M&A action as well. “I agree with the premise that […]

Home Health Stocks See Up-and-Down February

Home health stocks saw mixed success in February, according to the latest Home Health Index (HHI) from mergers-and-acquisitions advisory firm Stoneridge Partners. The up-and-down February follows a largely positive January. Updated monthly, the HHI by Stoneridge Partners tracks the market values for Amedisys Inc. (Nasdaq: AMED) and LHC Group Inc. (Nasdaq: LHCG). Overall, the HHI […]

Amedisys, LHC Group Stock Up More Than 11% in January

For the most part, home health stocks performed well in January, with Amedisys Inc. (Nasdaq: AMED) and LHC Group Inc. (Nasdaq: LHCG) both seeing double-digit gains. But while Amedisys and LHC Group saw their stock values climb, Addus HomeCare Corporation (Nasdaq: ADUS) saw its stock dip. That’s according to the latest Home Health Index (HHI) […]

Panel Preview: M&A Outlook — Capital + Strategy Forum

Panel Spotlight | M&A Outlook: Expanding The Continuum Through New Services Lines  Join us in the nation’s capital for a day of networking and thought leadership with industry executives in home health, private duty and hospice care. In this featured panel, you will hear how home health company valuations and deals have seen continued momentum in 2018. […]

Home Health Stocks Recover After Down October, Flat September

After a down couple of months mirroring broader economic trends, home health stocks are headed back up. Home health stocks climbed by more than 21% in November compared to the previous month, according to the most recent Home Health Index (HHI) from Stoneridge Partners, a mergers-and-acquisitions firm based in Louisville, Kentucky. The HHI is a […]

What Is The Capital + Strategy Forum & Why You Need To Be Here

HHCN’s Capital + Strategy Forum is NOT your typical industry conference — it is a catalyst for innovation in the changing home health care space. It brings together the brightest minds to share forward-looking ideas, inspirations and innovations in every aspect of home health, hospice, private duty and more. This is a first-class opportunity to network with thought leaders […]

Amedisys, LHC Group Shares Hit October Slowdown

While home health stocks rode M&A momentum and other tailwinds to an overall strong performance throughout much of 2018, the sustained boom period slowed down in September. Amid a broader market dip, that slowdown turned into an abrupt stop last month. Home health stocks fell more than 11% in October compared to their September standings, […]

Home Health Stocks Show Signs of Cooling Off

Fueled by savvy moves from the United States’ two top independent and publicly traded home-based health care providers, home health stocks had seen strong month-after-month growth in 2018. Those hot growth levels now appear to be cooling off. Home health stocks were up just 0.74% in September compared to the previous month, according to the […]

Home Health Investors Undaunted, Stocks Continue Upward March

Not much has shaken home health stocks so far in 2018 — not even the proposed Patient-Driven Groupings Model (PDGM) or the potential introduction of an updated pre-claim review initiative. Home health stocks appear to be continuing their upward march, according to the most recent update to Stoneridge Partners’ Home Health Index (HHI), updated monthly. […]

Amedisys, LHC Group, Addus Shares Rise Despite PDGM Concerns

The Centers for Medicare & Medicaid Services (CMS) last month proposed an overhaul to the current prospective payment system for the home health industry with a sweeping new model that experts say would drastically increase billing efforts and force a move away from therapy services. So far, the potential negatives of the Patient-Driven Groupings Model […]